Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Neurodegeneration Prevention in Mild TBI
NCT01952288Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of simvastatin in traumatic brain injury (TBI), Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE), sponsored by VA Office of Research & Development. Primary endpoint: Total tau at 12 months. Started Sep 2013; status: completed.
02
Drugs
simvastatin
03
Conditions
traumatic brain injury (TBI)Alzheimer's disease (AD)chronic traumatic encephalopathy (CTE)
Beyond the preview
Go deeper on NCT01952288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952288.